Results 351 to 360 of about 457,473 (371)

Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Pharmacological Research, 2016
Robert Roskoski
exaly  

Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus

Journal of Inflammation Research, 2023
exaly  

Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis

Gut, 2015
S. Klein, J. Rick, J. Lehmann, R. Schierwagen, Irela Schierwagen, L. Verbeke, K. Hittatiya, F. Uschner, S. Manekeller, C. Strassburg, K. Wagner, P. Sayeski, D. Wolf, W. Laleman, T. Sauerbruch, J. Trebicka   +15 more
semanticscholar   +1 more source

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Adam Golebiowski
exaly  

Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2).

Bioorganic & Medicinal Chemistry Letters, 2015
Qingjie Liu, D. Batt, J. Lippy, N. Surti, A. Tebben, J. Muckelbauer, Lin Chen, Yongmi An, Chiehying Y Chang, M. Pokross, Zheng Yang, Haiqing Wang, J. Burke, P. Carter, J. Tino   +14 more
semanticscholar   +1 more source

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

Journal of Dermatological Treatment, 2017
Aniseh Samadi, Saman Ahmad Nasrollahi, Ashkan Hashemi   +2 more
exaly  

Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.

European Journal of Cancer, 2016
G. Nagaraju, Anya I. Mezina, W. Shaib, J. Landry, B. El-Rayes   +4 more
semanticscholar   +1 more source

Calreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations

Leukemia and Lymphoma, 2015
Chao Sun, Sujiang Zhang, Jianyong Li
semanticscholar   +1 more source

Putamina Involvement in Wernicke Encephalopathy Induced by Janus Kinase 2 Inhibitor

Clinical neuropharmacology, 2015
Jorge Rodríguez-Pardo, I. Puertas-Muñoz, P. Martínez-Sánchez, Javier Díaz de Terán, I. Pulido-Valdeolivas, B. Fuentes   +5 more
semanticscholar   +1 more source

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

Journal of the American Academy of Dermatology, 2017
Lucy Y Liu, James P Strassner, John E Harris   +2 more
exaly